Complete Response Letters

Bioverativ USA, Inc.: sutimlimab

What FDA's Complete Response Letters to the company say, in the letters' own words.

EphemerisX Research · Sep 30, 2026 · Sources: FDA, SEC

Complete Response Letter, Nov 13, 2020

During a recent inspection of the © facility for this application, our field investigators conveyed deficiencies to the representative of the facility at the close of the inspection.

Complete Response Letter · Nov 13, 2020 · p. 3Open the letter at p. 3 ↗CRL_BLA761164_20201113:p1:s42

More Complete Response Letters

All companies in the CRL Tracker →

Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.